{"id":2132,"date":"2019-09-27T18:32:37","date_gmt":"2019-09-27T18:32:37","guid":{"rendered":"https:\/\/ring20researchsupport.co.uk\/?p=2132"},"modified":"2023-02-10T08:54:20","modified_gmt":"2023-02-10T08:54:20","slug":"crdn-raresummit19","status":"publish","type":"post","link":"https:\/\/ring20researchsupport.co.uk\/fr\/2019\/09\/crdn-raresummit19\/","title":{"rendered":"CRDN RAREsummit19"},"content":{"rendered":"<p>Sa semaine a \u00e9t\u00e9 \u00e9puisante mais exaltante, le point culminant \u00e9tant la pr\u00e9sence <a href=\"https:\/\/camraredisease.org\/summit-2019\/\">RAREsommet19 <\/a>au <a href=\"https:\/\/www.wellcomegenomecampus.org\/\">Bienvenue G\u00e9nome Campus<\/a> organis\u00e9 par le Cambridge Rare Disease Network le lundi 23 septembre 19.<\/p>\n<p>De la pr\u00e9sentation de notre derni\u00e8re affiche sur notre stand Ring20, \u00e0 la pr\u00e9sentation devant un auditorium rempli de 250 personnes, en passant par les nombreuses pistes de suivi en termes de collaboration future - et pour couronner le tout, j&#039;ai fait la BBC News ce soir-l\u00e0\u00a0! (regardez la vid\u00e9o :\u00a0<a href=\"https:\/\/ring20researchsupport.co.uk\/fr\/cause\/ring20-in-the-news\/\">Clip vid\u00e9o de BBC News<\/a>).<\/p>\n<p>C&#039;\u00e9tait un d\u00e9part matinal, conduire \u00e0 Cambridge depuis l&#039;Essex pour arriver \u00e0 8 heures du matin pour mettre en place notre nouvelle affiche et organiser le stand.<\/p>\n<p style=\"text-align: left;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-medium wp-image-2136 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-300x245.jpg\" alt=\"IMG_4841\" width=\"300\" height=\"245\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-300x245.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-1024x835.jpg 1024w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-768x626.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-1536x1252.jpg 1536w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-2048x1670.jpg 2048w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-16x12.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4841-600x489.jpg 600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p style=\"text-align: left;\">Le th\u00e8me que nous avons choisi pour notre affiche \u00e9tait \u00ab R\u00e9soudre le puzzle \u00bb du diagnostic. Le syndrome r(20) est per\u00e7u comme sous-diagnostiqu\u00e9 et probablement mal diagnostiqu\u00e9. Une grande partie du probl\u00e8me est le manque de sensibilisation des p\u00e9diatres et des neurologues aux signes et sympt\u00f4mes de r(20) qui sont tr\u00e8s similaires \u00e0 d&#039;autres \u00e9pilepsies rares telles que <a href=\"http:\/\/www.lgsfoundation.org.uk\/\">Syndrome de Lennox Gastaut<\/a> (LGS) en raison de l&#039;onde de pointe lente <span class='tooltipsall tooltipsincontent classtoolTips1'>EEG<\/span> motif et prolong\u00e9 <a href=\"https:\/\/www.epilepsy.com\/learn\/professionals\/resource-library\/epilepsy-behavior-articles\/presentation-evaluation-and\">\u00e9tat de mal \u00e9pileptique non convulsif (NCSE)<\/a>. Les tests de panel standard pour l&#039;\u00e9pilepsie g\u00e9n\u00e9tique NE d\u00e9tectent PAS actuellement l&#039;anneau <span class='tooltipsall tooltipsincontent classtoolTips0'>Chromosomes<\/span>, donc \u00e0 moins que le m\u00e9decin traitant ne sache demander un caryotype pour tester le mosa\u00efcisme chromosomique (et soumettre au moins 50 \u00e0 100 cellules - ce qui est plus que d&#039;habitude soumis), alors les chances qu&#039;un diagnostic r(20) soit fait sont en fait tr\u00e8s mince. Nous soup\u00e7onnons qu&#039;une proportion de patients avec d&#039;autres diagnostics d&#039;\u00e9pilepsie, par exemple LGS, peuvent en fait avoir r (20), mais n&#039;ont jamais eu les tests de diagnostic pour le prouver\u2026 SAVIEZ-VOUS QUE cet anneau <span class='tooltipsall tooltipsincontent classtoolTips0'>Chromosomes<\/span> 1 sur 50 000 naissances vivantes ? Alors, pourquoi n&#039;y a-t-il que 150 cas de r(20) cit\u00e9s dans la litt\u00e9rature m\u00e9dicale dans le monde - nous nous attendrions \u00e0 beaucoup plus...<\/p>\n<p><strong>Pourquoi le diagnostic est-il important ?<\/strong> Le diagnostic peut conduire \u00e0 diff\u00e9rentes options de soins et de traitement. Tr\u00e8s d&#039;actualit\u00e9 en ce moment, nous entendons tous parler de Cannabidiol (Epidyolex) dans les nouvelles qui est autoris\u00e9 aux \u00c9tats-Unis, et qui vient d&#039;\u00eatre approuv\u00e9 cette semaine par l&#039;EMA en Europe. Bien qu&#039;il reste encore du chemin \u00e0 parcourir pour que chaque pays europ\u00e9en d\u00e9termine s&#039;il convient d&#039;offrir Epidyolex dans le cadre de son propre syst\u00e8me de sant\u00e9 national, si et quand son utilisation est approuv\u00e9e, il ne sera initialement disponible que pour les personnes ayant un diagnostic de syndrome de Dravet ou de LGS en compl\u00e9ment. -sur Clobazam. Il peut s&#039;\u00e9couler un certain temps avant que ce traitement puisse \u00eatre prescrit <em>hors laboratoire<\/em>l \u00e0 d&#039;autres patients atteints d&#039;\u00e9pilepsie rare complexe tels que ceux atteints du syndrome r(20) \u2013 et pourtant, nous partageons les m\u00eames sympt\u00f4mes que de nombreux patients LGS\u00a0?<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-medium wp-image-2134 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-283x300.jpg\" alt=\"IMG_4870\" width=\"283\" height=\"300\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-283x300.jpg 283w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-965x1024.jpg 965w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-768x815.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-11x12.jpg 11w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870-600x637.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4870.jpg 1286w\" sizes=\"(max-width: 283px) 100vw, 283px\" \/>J&#039;ai eu le privil\u00e8ge de me voir offrir une place sur le panel de patients, donnant le coup d&#039;envoi des principaux d\u00e9bats de la journ\u00e9e. Nerveux, mais confiant dans mon sujet, je suis mont\u00e9 sur sc\u00e8ne et j&#039;ai attendu que mon cr\u00e9neau parle. Le th\u00e8me du panel \u00e9tait <strong>Des groupes de patients s&#039;associent au processus de d\u00e9veloppement de m\u00e9dicaments. S<em>quelque chose pour tout le monde?<\/em><\/strong> et mon adorable mentor <a href=\"http:\/\/www.draccon.com\/ana-mingorance\">Ana Mingorance<\/a> (photo ici) facilitait. Ana m&#039;a \u00e9t\u00e9 nomm\u00e9e par EURORDIS dans le cadre du programme de leadership que je suis cette ann\u00e9e et c&#039;\u00e9tait la premi\u00e8re r\u00e9union en face \u00e0 face pour nous, Ana est une neuroscientifique et a une exp\u00e9rience de travail dans la d\u00e9couverte et le d\u00e9veloppement de m\u00e9dicaments dans le secteur pharmaceutique industrie. Elle a travaill\u00e9 avec le <a href=\"https:\/\/dravet.eu\/\">Fondation Dravet<\/a> en Espagne et travaille maintenant avec le <a href=\"https:\/\/www.louloufoundation.org\/\">Fondation LouLou<\/a> (qui repr\u00e9sente CDKL5 une autre \u00e9pilepsie rare).<\/p>\n<p>Ma pr\u00e9sentation \u00e9tait centr\u00e9e sur le fait qu&#039;en tant que groupe de patients repr\u00e9sentant une maladie ultra-rare, nous sommes au tout d\u00e9but du parcours de d\u00e9veloppement de m\u00e9dicaments - en fait, nous avons encore du chemin \u00e0 parcourir pour m\u00eame faire nos premiers pas puisque nous avons un nombre limit\u00e9 de non . de cas diagnostiqu\u00e9s, pas de registre de patients, tr\u00e8s peu de recherche, pas de biomarqueurs et n&#039;ont jamais \u00e9t\u00e9 impliqu\u00e9s dans un essai clinique. Pourtant, je renverse la situation et je sugg\u00e8re que nous sommes m\u00fbrs pour l&#039;opportunit\u00e9\u00a0! J&#039;ai expliqu\u00e9 que, m\u00eame en tant qu&#039;organisation de patients atteints de maladies ultra-rares, nous pouvons toujours nous impliquer et rehausser le profil de la maladie que nous repr\u00e9sentons, ce qui est exactement ce que j&#039;ai fait gr\u00e2ce \u00e0 mon engagement dans <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>la <a href=\"https:\/\/ec.europa.eu\/health\/ern_en\">R\u00e9seau europ\u00e9en de r\u00e9f\u00e9rence (ERN)<\/a> pour les \u00e9pilepsies rares et complexes. En participant simplement aux discussions et en \u00e9tant pr\u00e9sent, r(20) est entendu et reconnu et je sais pertinemment que dans le syst\u00e8me de gestion clinique des patients (<a href=\"https:\/\/epi-care.eu\/clinical-patient-management-system-cpms-live-12pm-cet-20th-november-2017\/\">CPMS) <\/a>sessions \u2013 o\u00f9 des neurologues de toute l&#039;Europe discutent des cas les plus complexes lors d&#039;une session de consultation virtuelle \u2013 r\u00e9cemment, plusieurs cas ont \u00e9t\u00e9 sugg\u00e9r\u00e9s pour v\u00e9rifier un diagnostic r(20). M\u00eame s&#039;ils sont test\u00e9s et s&#039;av\u00e8rent ne pas \u00eatre r(20), c&#039;est un progr\u00e8s\u00a0! Nous travaillons \u00e9galement sur plusieurs initiatives pour produire du mat\u00e9riel \u00e9ducatif pour les cliniciens et les familles des patients dans le cadre de <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>\u2013 cela ne serait pas arriv\u00e9 si je n&#039;avais pas fait du b\u00e9n\u00e9volat pour eux\u2026<\/p>\n<p>Je pr\u00e9sente ici :<\/p>\n<div id='gallery-1' class='gallery galleryid-2132 gallery-columns-4 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4845\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2137\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4845-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2137'>\n\t\t\t\tPanneau de patients\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4848\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2138\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4848-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2138'>\n\t\t\t\tPartagez si vous \u00eates ultra-rare\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4851\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2140\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4851-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2140'>\n\t\t\t\t\u00c0 propos de nous\u2026\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4852\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-2141\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4852-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-2141'>\n\t\t\t\t\u00c0 propos du syndrome r(20)\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>Mon discours a \u00e9t\u00e9 enregistr\u00e9, je le partagerai donc au fur et \u00e0 mesure qu&#039;il sera disponible.<\/p>\n<p>Imm\u00e9diatement apr\u00e8s ma pr\u00e9sentation, j&#039;ai pris une pause-caf\u00e9 bien m\u00e9rit\u00e9e, mais j&#039;ai \u00e9t\u00e9 approch\u00e9 imm\u00e9diatement par deux repr\u00e9sentants de <a href=\"https:\/\/www.illumina.com\/\"><strong>Illumin\u00e9<\/strong> <\/a>(l&#039;entreprise derri\u00e8re les super-ordinateurs qui s\u00e9quencent le g\u00e9nome humain sur le campus dans le cadre du projet 100 000 g\u00e9nomes). Leur int\u00e9r\u00eat a \u00e9t\u00e9 piqu\u00e9 par mon discours et ils veulent parler davantage pour voir s&#039;ils peuvent nous aider. Jillian Hastings-Ward Pr\u00e9sidente du Royaume-Uni <a href=\"https:\/\/www.genomicsengland.co.uk\/about-genomics-england\/the-100000-genomes-project\/\"><strong>#G\u00e9nomes100k<\/strong><\/a> Le panneau des participants est pass\u00e9 \u00e0 c\u00f4t\u00e9 de mon stand pour dire bonjour aussi - nous nous sommes rencontr\u00e9s il y a quelques mois lorsque j&#039;ai pris la parole pour la derni\u00e8re fois au <strong>G\u00e9n\u00e9tique Sano<\/strong> un \u00e9v\u00e9nement. Ensuite, Mary Bythell, responsable de l&#039;enregistrement des maladies rares du Service national d&#039;enregistrement des anomalies cong\u00e9nitales et des maladies rares (<a href=\"https:\/\/www.gov.uk\/guidance\/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs\"><strong>NCARDRS<\/strong><\/a>). Nous avions d\u00e9j\u00e0 \u00e9t\u00e9 en contact avec <a href=\"https:\/\/www.gov.uk\/guidance\/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs\"><strong>NCARDRS<\/strong> <\/a>et ont d\u00e9couvert qu&#039;ils n&#039;avaient pas encore de dossiers de patients r(20), mais maintenant ils sont int\u00e9ress\u00e9s \u00e0 nous parler de la fa\u00e7on dont nous pouvons changer cela et nous avons d\u00e9j\u00e0 pr\u00e9vu un appel pour parler des prochaines \u00e9tapes.<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2133 alignright\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-300x225.jpg\" alt=\"UK Rare Disease Strategy diagram\" width=\"300\" height=\"225\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-300x225.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-768x576.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-16x12.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram-600x450.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/UK-Rare-Disease-Strategy-diagram.jpg 960w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Pour ceux d&#039;entre vous qui ne connaissent pas ces 3 organisations, elles forment la triade de services au Royaume-Uni cr\u00e9\u00e9e \u00e0 la suite de la\u00a0<a href=\"https:\/\/www.gov.uk\/government\/publications\/uk-strategy-for-rare-diseases-2019-update-to-the-implementation-plan-for-england\"><strong>Strat\u00e9gie britannique sur les maladies rares 2013-2020<\/strong><\/a>, qui doit \u00eatre renouvel\u00e9 prochainement. Ce sont des acteurs cl\u00e9s du s\u00e9quen\u00e7age\/diagnostic g\u00e9nomique (dont le Royaume-Uni est le leader mondial), de l&#039;enregistrement des maladies rares et de l&#039;acc\u00e8s \u00e0 la recherche pour les patients atteints de maladies rares. Nous voulons vraiment que r(20) soit sur leur radar et nous travaillons dur pour que cela se produise. (En fait, nous sommes \u00e9galement en conversation avec <a href=\"https:\/\/bioresource.nihr.ac.uk\/rare-diseases\/rare-diseases\/\">Unit\u00e9 des bioressources du NIHR<\/a> pour d\u00e9terminer comment nous pourrions obtenir une cohorte de chromosomes r (20) \/ anneau dans leurs livres.)<\/p>\n<p>Dans l&#039;apr\u00e8s-midi, nous avons \u00e9t\u00e9 mis au d\u00e9fi de participer \u00e0 un hackathon pr\u00e9sent\u00e9 par <a href=\"https:\/\/www.gov.uk\/government\/people\/nicola-blackwood\">Baronne Nicola Blackwood<\/a>, sous-secr\u00e9taire d&#039;\u00c9tat parlementaire au minist\u00e8re de la Sant\u00e9 et des Affaires sociales. La baronne Blackwood a elle-m\u00eame une maladie rare et est donc une avocate positive de notre communaut\u00e9. Nous nous sommes divis\u00e9s en groupes pour couvrir diff\u00e9rents sujets, notamment le diagnostic, la coordination des soins, l&#039;acc\u00e8s \u00e0 la recherche, le co\u00fbt du traitement et l&#039;autonomisation des patients. Il y a eu des discussions anim\u00e9es et je crie pour les maladies ultra-rares (y compris r(20)) o\u00f9 les besoins de base doivent simplement \u00eatre satisfaits en premier et qu&#039;il ne devrait pas incomber aux petites organisations de patients de \u00ab\u00a0table de cuisine\u00a0\u00bb de financer ces activit\u00e9s. par exemple, avoir un dossier des patients afin de savoir combien de personnes sont touch\u00e9es et comment elles peuvent \u00eatre contact\u00e9es pour participer \u00e0 la recherche. Les r\u00e9sultats ont \u00e9t\u00e9 discut\u00e9s en groupe entier et les th\u00e8mes cl\u00e9s seront r\u00e9dig\u00e9s et pr\u00e9sent\u00e9s \u00e0 la baronne Blackwood plus tard cette ann\u00e9e, en tant que contribution \u00e0 la prochaine strat\u00e9gie britannique sur les maladies rares. (C&#039;est le 3e \u00e9v\u00e9nement o\u00f9 je contribue \u00e0 cette strat\u00e9gie en une semaine, car j&#039;ai \u00e9galement travaill\u00e9 dans le cadre du sous-groupe sur les maladies rares pour l&#039;Alliance neurologique et j&#039;ai particip\u00e9 \u00e0 un \u00e9v\u00e9nement organis\u00e9 par Genetic Alliance UK , donc en tant que groupe de patients, nous avons d\u00e9finitivement notre mot \u00e0 dire et contribuons aux r\u00e9sultats finaux\u00a0!)<\/p>\n<div id='gallery-2' class='gallery galleryid-2132 gallery-columns-3 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/20190923_145704\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-2-2163\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_145704-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-2-2163'>\n\t\t\t\tLa baronne Blackwood lance le d\u00e9fi du hackathon\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/20190923_151726\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_151726-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/20190923_170521\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-2-2161\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/20190923_170521-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-2-2161'>\n\t\t\t\tLes r\u00e9sultats sont l\u00e0 et la recherche est en t\u00eate de l&#039;ordre du jour\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>Il y avait beaucoup d&#039;amis et de connaissances \u00e0 retrouver \u00e0 <a href=\"https:\/\/camraredisease.org\/summit-2019\/\"><strong>RAREsommet19<\/strong> \u00a0<\/a>y compris <a href=\"https:\/\/www.rarerevolutionmagazine.com\/\"><strong>Rare R\u00e9volution<\/strong><\/a>, <a href=\"https:\/\/www.findacure.org.uk\/\"><strong>Trouver un rem\u00e8de<\/strong><\/a>, <a href=\"https:\/\/www.akusociety.org\/\"><strong>Soci\u00e9t\u00e9 AKU<\/strong><\/a>, compagnon <a href=\"https:\/\/www.eurordis.org\/content\/epags\">EPAG <\/a>repr\u00e9sentants, y compris de <a href=\"http:\/\/pitthopkins.org.uk\/\"><strong>Pitt Hopkins<\/strong><\/a>, Jelena Aleksic de\u00a0<strong><a href=\"https:\/\/www.sparkbio.it\/\">Sparkbio<\/a>, <\/strong>Patrick Court de <a href=\"https:\/\/sanogenetics.com\/\"><strong>G\u00e9n\u00e9tique Sano<\/strong><\/a>\u2026la liste continue. Bien qu&#039;il y ait plus de 8 000 maladies rares, la communaut\u00e9 des patients est assez \u00e9troite et forte et nous nous soutenons tous comme une grande famille. Ron Jortner (de\u00a0<a href=\"https:\/\/www.masthead-biosciences.com\/\"><strong>Titre Biosciences<\/strong><\/a> et fiduciaire pour <a href=\"https:\/\/camraredisease.org\/\">CRDN<\/a>) m&#039;a r\u00e9cemment contact\u00e9 \u00e0 propos de r(20) et nous a inclus dans l&#039;une de ses conf\u00e9rences - il aimerait maintenant poursuivre avec une opportunit\u00e9 potentielle pour nous de pr\u00e9senter aux soci\u00e9t\u00e9s pharmaceutiques dans un proche avenir.<\/p>\n<div id='gallery-3' class='gallery galleryid-2132 gallery-columns-3 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4866\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2144\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4866-e1569594361280-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2144'>\n\t\t\t\tavec Jillian Hastings Ward\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4861\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2142\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4861-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2142'>\n\t\t\t\tIllumin\u00e9\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/img_4867\/'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-3-2145\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2019\/09\/IMG_4867-e1569594420384-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-2145'>\n\t\t\t\tRon Jortner\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<p>L&#039;une des organisatrices, Joanna Segeith (de\u00a0<a href=\"http:\/\/biosynetix.co.uk\/\"><strong>Biosynetix<\/strong><\/a>) nous a contact\u00e9 avant l&#039;\u00e9v\u00e9nement et nous avons eu une br\u00e8ve conversation le jour m\u00eame. Joanna a une id\u00e9e pour une opportunit\u00e9 de recherche pour des essais \u00ab en panier \u00bb et nous allons parler au professeur Helen Cross pour savoir comment nous trois pourrions faire avancer cette id\u00e9e.<\/p>\n<p><strong>Le simple fait de sortir et de parler du syndrome r(20) nous fait vraiment remarquer.\u00a0<\/strong>Perhaps next time one of you will join me as I could really use the support \ud83d\ude09<\/p>\n<p>Vous pensez peut-\u00eatre que de nombreuses opportunit\u00e9s de cet \u00e9v\u00e9nement sont bas\u00e9es au Royaume-Uni, mais nous devons faire de petits pas et commencer quelque part. Mon travail avec <a href=\"https:\/\/epi-care.eu\/\">EpiCARE <\/a>signifie que nous travaillons \u00e9galement au niveau europ\u00e9en. Prochain arr\u00eat pour conqu\u00e9rir le monde \u2013 un pas \u00e0 la fois\u2026 hein ?<\/p>\n<p>Je vous tiendrai au courant de tout d\u00e9veloppement.\u00a0<strong>C&#039;est vraiment l\u00e0 que la magie op\u00e8re !<\/strong><\/p>\n<script type=\"text\/javascript\"> toolTips('.classtoolTips0','Chromosomes are long string-like structures that store all of our DNA. Each cell in the human body usually has 23 pairs of chromosomes (or 46 chromosomes in total).'); <\/script><script type=\"text\/javascript\"> toolTips('.classtoolTips1','Electroencephalography'); <\/script>","protected":false},"excerpt":{"rendered":"<p>Sa semaine a \u00e9t\u00e9 \u00e9puisante mais exaltante, le point culminant \u00e9tant la participation au RAREsummit19 au Wellcome Genome Campus organis\u00e9 par le Cambridge Rare Disease Network le lundi 23 septembre 19.<\/p>","protected":false},"author":3,"featured_media":1254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[42],"tags":[],"class_list":["post-2132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRDN RAREsummit19 - Ring20 Research and Support UK CIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ring20researchsupport.co.uk\/fr\/2019\/09\/crdn-raresummit19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRDN RAREsummit19 - Ring20 Research and Support UK CIO\" \/>\n<meta property=\"og:description\" content=\"Its been and exhausting but exhilarating week, the highlight being attending RAREsummit19 at the Wellcome Genome Campus organised by the Cambridge Rare Disease Network on Monday 23rd Sept 19.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ring20researchsupport.co.uk\/fr\/2019\/09\/crdn-raresummit19\/\" \/>\n<meta property=\"og:site_name\" content=\"Ring20 Research and Support UK CIO\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-27T18:32:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T08:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alison\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alison\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"},\"author\":{\"name\":\"Alison\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\"},\"headline\":\"CRDN RAREsummit19\",\"datePublished\":\"2019-09-27T18:32:37+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"},\"wordCount\":1572,\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"articleSection\":[\"Events\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\",\"name\":\"CRDN RAREsummit19 - Ring20 Research and Support UK CIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"datePublished\":\"2019-09-27T18:32:37+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2014\\\/12\\\/600x450-r20-hoodie-front-logo.jpg\",\"width\":600,\"height\":450,\"caption\":\"Hoodie - logo close up\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2019\\\/09\\\/crdn-raresummit19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRDN RAREsummit19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"name\":\"Ring20 Research and Support UK CIO\",\"description\":\"Promoting research, education and continuous support to end undiagnosed and misdiagnosed Ring20 epilepsy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\",\"name\":\"Ring20 Research and Support CIO\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"width\":2357,\"height\":666,\"caption\":\"Ring20 Research and Support CIO\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\",\"name\":\"Alison\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"caption\":\"Alison\"},\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/fr\\\/author\\\/alison\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRDN RAREsummit19 - Recherche et soutien Ring20 UK CIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ring20researchsupport.co.uk\/fr\/2019\/09\/crdn-raresummit19\/","og_locale":"fr_FR","og_type":"article","og_title":"CRDN RAREsummit19 - Ring20 Research and Support UK CIO","og_description":"Its been and exhausting but exhilarating week, the highlight being attending RAREsummit19 at the Wellcome Genome Campus organised by the Cambridge Rare Disease Network on Monday 23rd Sept 19.","og_url":"https:\/\/ring20researchsupport.co.uk\/fr\/2019\/09\/crdn-raresummit19\/","og_site_name":"Ring20 Research and Support UK CIO","article_published_time":"2019-09-27T18:32:37+00:00","article_modified_time":"2023-02-10T08:54:20+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","type":"image\/jpeg"}],"author":"Alison","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Alison","Dur\u00e9e de lecture estim\u00e9e":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#article","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"},"author":{"name":"Alison","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac"},"headline":"CRDN RAREsummit19","datePublished":"2019-09-27T18:32:37+00:00","dateModified":"2023-02-10T08:54:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"},"wordCount":1572,"publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","articleSection":["Events"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/","url":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/","name":"CRDN RAREsummit19 - Recherche et soutien Ring20 UK CIO","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","datePublished":"2019-09-27T18:32:37+00:00","dateModified":"2023-02-10T08:54:20+00:00","breadcrumb":{"@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#primaryimage","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2014\/12\/600x450-r20-hoodie-front-logo.jpg","width":600,"height":450,"caption":"Hoodie - logo close up"},{"@type":"BreadcrumbList","@id":"https:\/\/ring20researchsupport.co.uk\/2019\/09\/crdn-raresummit19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ring20researchsupport.co.uk\/"},{"@type":"ListItem","position":2,"name":"CRDN RAREsummit19"}]},{"@type":"WebSite","@id":"https:\/\/ring20researchsupport.co.uk\/#website","url":"https:\/\/ring20researchsupport.co.uk\/","name":"Ring20 Research and Support DSI Royaume-Uni","description":"Promouvoir la recherche, l&#039;\u00e9ducation et le soutien continu pour mettre fin \u00e0 l&#039;\u00e9pilepsie Ring20 non diagnostiqu\u00e9e et mal diagnostiqu\u00e9e","publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ring20researchsupport.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ring20researchsupport.co.uk\/#organization","name":"DSI de la recherche et du support Ring20","url":"https:\/\/ring20researchsupport.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","width":2357,"height":666,"caption":"Ring20 Research and Support CIO"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac","name":"Alison","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","caption":"Alison"},"url":"https:\/\/ring20researchsupport.co.uk\/fr\/author\/alison\/"}]}},"_links":{"self":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/2132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/comments?post=2132"}],"version-history":[{"count":1,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/2132\/revisions"}],"predecessor-version":[{"id":10384,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/2132\/revisions\/10384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/media\/1254"}],"wp:attachment":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/media?parent=2132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/categories?post=2132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/tags?post=2132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}